This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Healthcare Names: AbbVie (ABBV), HealthStream (HSTM) and Cigna (CI)

Tipranks - Tipranks - Tue Aug 4, 7:34AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV), HealthStream (HSTM) and Cigna (CI).

Claim 55% Off TipRanks

AbbVie (ABBV)

Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on AbbVie today and set a price target of $285.00. The company’s shares closed last Friday at $250.94.

According to TipRanks.com, Gould is a 4-star analyst with an average return of 6.1% and a 51.8% success rate. Gould covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Bristol-Myers Squibb, and Gilead Sciences. ;'>

Currently, the analyst consensus on AbbVie is a Strong Buy with an average price target of $274.76, representing an 8.8% upside. In a report issued on July 20, TipRanks – Google also upgraded the stock to Buy with a $281.00 price target.

See today’s best-performing stocks on TipRanks >>

HealthStream (HSTM)

Barrington analyst Vincent Colicchio maintained a Hold rating on HealthStream today. The company’s shares closed last Friday at $28.04.

According to TipRanks.com, Colicchio is a 5-star analyst with an average return of 10.4% and a 53.8% success rate. Colicchio covers the Technology sector, focusing on stocks such as Information Services Group, Climb Global Solutions, and TD SYNNEX Corporation. ;'>

HealthStream has an analyst consensus of Moderate Buy, with a price target consensus of $33.50, a 19.9% upside from current levels. In a report issued on July 20, Canaccord Genuity also maintained a Hold rating on the stock with a $27.00 price target.

Cigna (CI)

In a report released yesterday, Scott Fidel from Goldman Sachs maintained a Buy rating on Cigna, with a price target of $352.00. The company’s shares closed last Friday at $279.05, close to its 52-week low of $262.03.

According to TipRanks.com, Fidel is a 4-star analyst with an average return of 7.4% and a 62.7% success rate. Fidel covers the Healthcare sector, focusing on stocks such as BrightSpring Health Services, Inc., Lifestance Health Group, and Alignment Healthcare. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cigna with a $347.94 average price target, a 22.0% upside from current levels. In a report issued on July 21, Bernstein also maintained a Buy rating on the stock with a $381.00 price target.

Read More on ABBV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).